These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 35599109
1. Chronic kidney disease and radical cystectomy for bladder cancer: perioperative and oncologic outcomes in 1,214 patients. Nguyen C, Ghodoussipour S, Winter M, Cacciamani G, Ahmadi H, Djaladat H, Schuckman AK, Daneshmand S, Aron M, Gill I, Desai M. Urol Oncol; 2022 Aug; 40(8):381.e9-381.e16. PubMed ID: 35599109 [Abstract] [Full Text] [Related]
2. Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function. Sari Motlagh R, Ghoreifi A, Yanagisawa T, Kawada T, Kikic Z, Gill I, Daneshmand S, Djaladat H, Shariat SF. Eur Urol Focus; 2024 Jan; 10(1):169-181. PubMed ID: 37442723 [Abstract] [Full Text] [Related]
3. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045 [Abstract] [Full Text] [Related]
6. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy. Chalfin HJ, Liu JJ, Gandhi N, Feng Z, Johnson D, Netto GJ, Drake CG, Hahn NM, Schoenberg MP, Trock BJ, Scott AV, Frank SM, Bivalacqua TJ. Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987 [Abstract] [Full Text] [Related]
7. Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care. Chappidi MR, Kates M, Stimson CJ, Johnson MH, Pierorazio PM, Bivalacqua TJ. J Urol; 2017 Feb; 197(2):296-301. PubMed ID: 27545575 [Abstract] [Full Text] [Related]
9. Comparative effectiveness of robot-assisted vs. open radical cystectomy. Hanna N, Leow JJ, Sun M, Friedlander DF, Seisen T, Abdollah F, Lipsitz SR, Menon M, Kibel AS, Bellmunt J, Choueiri TK, Trinh QD. Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584 [Abstract] [Full Text] [Related]
10. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group. BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486 [Abstract] [Full Text] [Related]
11. Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients. Thompson RH, Boorjian SA, Kim SP, Cheville JC, Thapa P, Tarrel R, Dronca R, Costello B, Frank I. BJU Int; 2014 May; 113(5b):E17-21. PubMed ID: 24006893 [Abstract] [Full Text] [Related]
12. Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy. Tan WS, Lamb BW, Khetrapal P, Tan MY, Tan ME, Sridhar A, Cervi E, Rodney S, Busuttil G, Nathan S, Hines J, Shaw G, Mohammed A, Baker H, Briggs TP, Klein A, Richards T, Kelly JD. J Endourol; 2017 Feb; 31(2):141-148. PubMed ID: 27901350 [Abstract] [Full Text] [Related]
15. Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC. Aldhaam NA, Elsayed AS, Jing Z, Richstone L, Wagner AA, Rha KH, Yuh B, Palou J, Khan MS, Menon M, Roupret M, Balbay D, Hosseini A, Wiklund P, Gaboardi F, Maatman TJ, Mottrie A, Wijburg C, Stöckle M, Hemal A, Kim E, Kaouk J, Hussein AA, Guru KA. J Urol; 2020 Jan; 203(1):57-61. PubMed ID: 31600114 [Abstract] [Full Text] [Related]
16. The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study. Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, Jokisch F. World J Urol; 2024 Mar 15; 42(1):164. PubMed ID: 38489039 [Abstract] [Full Text] [Related]
17. Restrictive transfusion in radical cystectomy is safe. Syan-Bhanvadia S, Drangsholt S, Shah S, Cai J, Miranda G, Djaladat H, Daneshmand S. Urol Oncol; 2017 Aug 15; 35(8):528.e15-528.e21. PubMed ID: 28476526 [Abstract] [Full Text] [Related]
18. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy. Moschini M, Morlacco A, Briganti A, Hu B, Colombo R, Montorsi F, Frank I, Daneshmand S, Karnes RJ. Eur Urol Focus; 2018 Mar 15; 4(2):245-251. PubMed ID: 28753820 [Abstract] [Full Text] [Related]
19. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Bhindi B, Frank I, Mason RJ, Tarrell RF, Thapa P, Cheville JC, Costello BA, Pagliaro LC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. Eur Urol; 2017 Nov 15; 72(5):660-664. PubMed ID: 28545841 [Abstract] [Full Text] [Related]
20. Radical cystectomy and urinary diversion outcomes in patients with single vs. double renal unit: A 2:1 matched-pair analysis. Mora RM, Ghoreifi A, Ladi-Seyedian SS, Sheybaee Moghaddam F, Cai J, Miranda G, Aron M, Schuckman A, Desai M, Gill I, Daneshmand S, Djaladat H. Urol Oncol; 2023 Apr 15; 41(4):207.e17-207.e22. PubMed ID: 36566106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]